| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Mar―05 |
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial |
Laurent Alric, Clara Brusq, Marion Migueres, Stephanie Faure, Pascal Lebray, Jean François Viallard, et al. (+5) Dominique Chauveau, Laurent Sailler, Emilie Bérard, Grégory Pugnet, Patrice Cacoub |
| 2 |
[GO] |
2024―Oct―01 |
SARS-CoV-2 spike aggravates lupus nephritis and lung fibrosis in systemic lupus erythematosus |
Yeon Su Lee, Jin Seok Woo, JooYeon Jhun, Jeong Won Choi, A Ram Lee, Kun Hee Lee, et al. (+3) Haeyoun Choi, Sung-Hwan Park, Mi-La Cho |
| 3 |
[GO] |
2024―Sep―21 |
Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus |
Esra Karabag Yilmaz, Ayse Agbas, Nur Canpolat, Aybuke Gunalp, Sezgin Sahin, Dogukan Ozbey, et al. (+5) Ruveyda Gulmez, Seha Kamil Saygili, Bekir Kocazeybek, Ozgur Kasapcopur, Salim Caliskan |
| 4 |
[GO] |
2024―Feb―09 |
Does the use of corticosteroids and immunosuppressants increase the risk of COVID-19 infection among people with systemic lupus erythematosus? |
Laurence S Magder, Andrea Fava, Daniel Goldman, Michelle A Petri |
| 5 |
[GO] |
2024―Feb―01 |
Large overlap in neutrophil transcriptome between lupus and COVID-19 with limited lupus-specific gene expression |
Rayan Najjar, Noga Rogel, Jose Mario Bello Pineda, Xiaoxing Wang, Megan Tran, Alison Bays, Tomas Mustelin |
| 6 |
[GO] |
2023―Oct―17 |
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology |
Chiara Scirocco, Sara Ferrigno, Laura Andreoli, Micaela Fredi, Claudia Lomater, Luca Moroni, et al. (+8) Marta Mosca, Bernd Raffeiner, Greta Carrara, Gianpiero Landolfi, Davide Rozza, Anna Zanetti, Carlo Alberto Scirè, Gian Domenico Sebastiani |
| 7 |
[GO] |
2023―Jul―12 |
COVID-19 vaccination questionnaire in patients with systemic lupus erythematosus: an observational study |
Rui-Juan Cheng, Yan-Hong Li, Zhi-Hui Liu, Aiping Zhou, Zhuhong Li, Ling Ma, Yi Liu |
| 8 |
[GO] |
2023―Feb―14 |
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus |
Sebastian Bruera, Xiudong Lei, Hui Zhao, Jinoos Yazdany, Mariana Chavez-MacGregor, Sharon H Giordano, Maria E Suarez-Almazor |
| 9 |
[GO] |
2022―Oct―31 |
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic |
Francesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Murray B Urowitz, et al. (+27) Guillermo Ruiz-Irastorza, Sasha Bernatsky, Daniel J Wallace, Michelle A Petri, Susan Manzi, Sang-Cheol Bae, Jung-Min Shin, Anselm Mak, Jiacai Cho, Christine A Peschken, Rosalind Ramsey-Goldman, Paul R Fortin, John G Hanly, Bernardo A Pons-Estel, Romina Nieto, Anca D Askanase, Juanita Romero-Diaz, Marta Mosca, Ian N Bruce, Leigha Rowbottom, Leanne Mielczarek, Karin Tse, Ashley Marion, Juan Carlos Cáhiz-González, Teresa G Cattoni, Alain Cornet, Ann Elaine Clarke |
| 10 |
[GO] |
2022―Aug―24 |
Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
Shu Ran, Lixin Pan, Baolin Liu |
| 11 |
[GO] |
2022―Aug―12 |
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus |
Tsuneyasu Yoshida, Hideaki Tsuji, Akira Onishi, Yudai Takase, Mirei Shirakashi, Hideo Onizawa, et al. (+7) Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Masao Tanaka, Hajime Yoshifuji, Akio Morinobu |
| 12 |
[GO] |
2022―Jul―28 |
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis |
Theerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, et al. (+2) Nawaporn Assawasaksakul, Wonngarm Kittanamongkolchai |
| 13 |
[GO] |
2022―Apr―07 |
Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort |
May Y Choi, Ann Elaine Clarke, Katherine Buhler, Michelle Jung, Hannah Mathew, Meifeng Zhang, et al. (+3) Francesca S Cardwell, Heather Waldhauser, Marvin J Fritzler |
| 14 |
[GO] |
2022―Feb―17 |
Association of COVID-19 pandemic-related concern and health routine changes with functioning among individuals with systemic lupus erythematosus |
Laura C Plantinga, Courtney Hoge, Charmayne Dunlop-Thomas, Brad D Pearce, S Sam Lim, Cristina Drenkard, C Barrett Bowling |
| 15 |
[GO] |
2021―Apr―19 |
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety |
Alain Cornet, Jeanette Andersen, Chiara Tani, Marta Mosca |
| 16 |
[GO] |
2021―Mar―18 |
Correction: SARS-CoV-2 vaccines in patients with SLE |
|
| 17 |
[GO] |
2021―Mar―10 |
Development and implementation of a virtual Lupus Patient Education Event during the COVID-19 pandemic |
Mithu Maheswaranathan, Jessica A English, Melissa A Cunningham, Diane L Kamen |
| 18 |
[GO] |
2021―Mar―08 |
SARS-CoV-2 vaccines in patients with SLE |
Wei Tang, Anca D Askanase, Leila Khalili, Joan T Merrill |
| 19 |
[GO] |
2020―May―19 |
Could severe COVID-19 be considered a complementopathy? |
Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini |
| 20 |
[GO] |
2020―May―06 |
Impact of COVID-19 pandemic on SLE: beyond the risk of infection |
Alice Horisberger, Laura Moi, Camillo Ribi, Denis Comte |
| 21 |
[GO] |
2020―Apr―03 |
Thoughts on COVID-19 and autoimmune diseases |
Anca D Askanase, Leila Khalili, Jill P Buyon |
|
